lm11a-31 has been researched along with Tauopathies* in 1 studies
1 other study(ies) available for lm11a-31 and Tauopathies
| Article | Year |
|---|---|
Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice.
In tauopathies, phosphorylation, acetylation, cleavage and other modifications of tau drive intracellular generation of diverse forms of toxic tau aggregates and associated seeding activity, which have been implicated in subsequent synaptic failure and neurodegeneration. Suppression of this wide range of pathogenic species, seeding and toxicity mechanisms, while preserving the physiological roles of tau, presents a key therapeutic goal. Identification and targeting of signaling networks that influence a broad spectrum of tau pathogenic mechanisms might prevent or reverse synaptic degeneration and modify disease outcomes. The p75 neurotrophin receptor (p75 Topics: Animals; Hippocampus; Humans; Isoleucine; Male; Mice; Mice, Transgenic; Morpholines; Receptors, Nerve Growth Factor; Tauopathies | 2020 |